Business Description
Aptinyx Inc
NAICS : 325412
SIC : 2834
ISIN : US03836N1037
Description
Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.64 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 1.49 | |||||
| Debt-to-EBITDA | -0.44 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.8 | |||||
| 3-Year EPS without NRI Growth Rate | 17.5 | |||||
| 3-Year FCF Growth Rate | 17.2 | |||||
| 3-Year Book Growth Rate | -42.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.41 | |||||
| 9-Day RSI | 38.95 | |||||
| 14-Day RSI | 42.5 | |||||
| 6-1 Month Momentum % | -49.59 | |||||
| 12-1 Month Momentum % | -82.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.12 | |||||
| Quick Ratio | 5.12 | |||||
| Cash Ratio | 4.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.1 | |||||
| Shareholder Yield % | -92.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -134.92 | |||||
| ROA % | -84.77 | |||||
| ROIC % | -975.49 | |||||
| ROC (Joel Greenblatt) % | -2453.15 | |||||
| ROCE % | -86.57 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.26 | |||||
| Price-to-Tangible-Book | 0.26 | |||||
| EV-to-EBIT | 0.2 | |||||
| EV-to-EBITDA | 0.21 | |||||
| EV-to-FCF | 0.23 | |||||
| Price-to-Net-Current-Asset-Value | 0.26 | |||||
| Price-to-Net-Cash | 0.31 | |||||
| Earnings Yield (Greenblatt) % | 500 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:APTX
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptinyx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.98 | ||
| Beta | 1.4 | ||
| Volatility % | 114.74 | ||
| 14-Day RSI | 42.5 | ||
| 14-Day ATR ($) | 0.003755 | ||
| 20-Day SMA ($) | 0.069959 | ||
| 12-1 Month Momentum % | -82.6 | ||
| 52-Week Range ($) | 0.05 - 0.72 | ||
| Shares Outstanding (Mil) | 67.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptinyx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptinyx Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aptinyx Inc Frequently Asked Questions
What is Aptinyx Inc(APTX)'s stock price today?
The current price of APTX is $0.07. The 52 week high of APTX is $0.72 and 52 week low is $0.05.
When is next earnings date of Aptinyx Inc(APTX)?
The next earnings date of Aptinyx Inc(APTX) is 2023-11-09 Est..
Does Aptinyx Inc(APTX) pay dividends? If so, how much?
Aptinyx Inc(APTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers